CI-992

CAS : 135704-06-2

Ref. 3D-KFA70406

Informations sur le produit

• Nom: CI-992
• Synonymes: N-(4-Morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl)-N-((1S,2R,3S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl)-L-alaninamide, N-(4-Morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl)-N-(1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl)-L-alaninamide, L-Alaninamide, N-(4-morpholinylsulfonyl)-L-phenylalanyl-3-(2-amino-4-thiazolyl)-N-((1S,2R,3S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl)-, N-[(2S)-3-(2-amino-1,3-thiazol-4-yl)-2-{[(1S,2R,3S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]amino}propanoyl]-Nalpha-(morpholin-4-ylsulfonyl)-L-phenylalaninamide

Description

CI-992 is an analog of a Chinese medicinal compound that has been developed as an inhibitor of cancer cell growth. It induces apoptosis, or programmed cell death, in tumor cells by inhibiting the activity of protein kinases involved in the regulation of the cell cycle. CI-992 has shown promising results as an anticancer agent in preclinical studies, demonstrating potent activity against a range of human cancer cell lines. This compound is currently being evaluated for its potential use in the treatment of various types of cancer and may represent a promising new class of cancer inhibitors.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 708.9 g/mol
• Formule: C₃₃H₅₂N₆O₇S₂
• Degré de pureté: Min. 95%